Acute, Affective, Organic Disorders.

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT00201474
Collaborator
St. Olavs Hospital (Other), Dr. Dedichens Institute for Psychiatric Research, Oslo, Norway. (Other), GlaxoSmithKline (Industry)
32
1
140
0.2

Study Details

Study Description

Brief Summary

The purpose of the study is to investigate whether patients with brief depressive periods together with other fluctuating psychiatric symptoms, have this condition due to epilepsy or an other organic brain disorder.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A limited number of patients admitted to psychiatric acute wards or Psychiatric Intensive Care Units are admitted with a fluctuating array of psychiatric symptoms including brief depressive episodes. These patients do not fit into the present diagnostic systems due to short duration of affective symptoms and the fluctuating arrays of other symptoms. Case histories indicate that these patients have psychiatric conditions due to epilepsy or organic brain dysfunctions.

    In the study acutely admitted patients filling criteria for two recent DSM-4 axis 1 diagnoses (one is a brief depressive period) during the last two weeks are compared to age- and sex-matched patients acutely admitted with a major depressive disorder. The patients are rated with a number of rating scales at admittance, day 5, after two weeks and three months. EEG and QEEG are taken three times the first week. MRI, drug screening and blood screening of medication-concentrations are taken.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    32 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Signs of Organic Brain Dysfunction in Psychiatric Patients With Fluctuating Psychiatric Symptoms Including Brief Depressions Compared to Patients With a Major Depressive Episode.
    Study Start Date :
    Oct 1, 1998
    Actual Primary Completion Date :
    Oct 1, 2004
    Actual Study Completion Date :
    Jun 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    brief depressive periods

    brief depressive periods together with other fluctuating psychiatric symptoms

    major depressive disorder

    Outcome Measures

    Primary Outcome Measures

    1. epilepsy or an other organic brain disorder [1 week]

      EEG and QEEG are taken three times in the first week

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Acutely admitted psychiatric patients who have at different times the last 2 weeks filled criteria for at least two new DSM-4 Axis 1 psychiatric diagnoses. One of them has to be a depressive episode (MADRS>20)
    Exclusion Criteria:
    • Patients not speaking Norwegian or English.

    • Patients not willing to participate.

    • Patients with dementia or mental retardation to an extensive degree.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Østmarka Psychiatric Department, St. Olavs Hospital Trondheim Norway 7441

    Sponsors and Collaborators

    • Norwegian University of Science and Technology
    • St. Olavs Hospital
    • Dr. Dedichens Institute for Psychiatric Research, Oslo, Norway.
    • GlaxoSmithKline

    Investigators

    • Study Chair: Olav M Linaker, Professor, Norwegian University of Science and Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00201474
    Other Study ID Numbers:
    • AEV-98
    First Posted:
    Sep 20, 2005
    Last Update Posted:
    Aug 4, 2016
    Last Verified:
    Aug 1, 2016

    Study Results

    No Results Posted as of Aug 4, 2016